They'll roll out the 10B platelet dosing across all 176 locations in the USA, along with blood analysis/patient registry to measure the outcome data. Looking forward to hearing about this.
Joseph Spine Institute launches its Center for Regenerative Spine Medicine in Tampa, offering minimally invasive stem cell therapies for chronic spinal conditions.
Nature Cell Co., Ltd. announced that its cell therapy product, JointStem, has been granted Breakthrough Therapy Designation (BTD) by the U.S. FDA, marking a first for a Korean company in this field....
Recent clinical data presented at the AAOS 2025 Annual Meeting in San Diego suggest that MEDIPOST's stem cell therapy, Cartistem, may offer a more effective treatment for severe knee osteoarthritis (OA) compared...
Colombus-based Atreon Orthopedics says they've received 510(k) clearance from the FDA for its BioCharge® Autobiologic Matrix. This bioresorbable synthetic implant is designed to address biological failure modes in rotator cuff repair, potentially...
Hope Biosciences has reportedly received FDA authorization to conduct a pediatric clinical trial using their adipose(fat)-derived mesenchymal stem cells (HB-adMSCs) to assess their impact on juvenile idiopathic arthritis (JIA) in children aged...
Alpine Spine & Orthopedics, a regenerative medicine clinic in Utah, has added a new C-Arm from Siemens, the Ciartic Move 3D imaging system. Alpine reports that this system is among the most...
Link to study, found in the journal named Reports, dated 2024. The problem? Neuropathy of the lower leg caused by tarsal tunnel syndrome Symptoms include Sharp shooting pain Pins/needles Electric shock/burning sensations...
Link to study, found in the Regenerative Medicine Journal, dated August 2021. The problem? Knee osteoarthritis The treatment studied? 2 injections of 40 million expanded (passage 3) Wharton's Jelly mesenchymal stem cells...
BioRestorative Therapies, a regenerative medicine company focused on stem cell-based therapies, has announced that the FDA has cleared its Investigational New Drug (“IND”) application for BRTX-100, a novel cell-based therapeutic engineered to...
